276 related articles for article (PubMed ID: 31259424)
1. Extracellular vesicles transmitted miR-31-5p promotes sorafenib resistance by targeting MLH1 in renal cell carcinoma.
He J; He J; Min L; He Y; Guan H; Wang J; Peng X
Int J Cancer; 2020 Feb; 146(4):1052-1063. PubMed ID: 31259424
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-induced microRNA-155 overexpression in extracellular vesicles promotes renal cell carcinoma progression by targeting
Meng L; Xing Z; Guo Z; Qiu Y; Liu Z
Aging (Albany NY); 2021 Mar; 13(7):9613-9626. PubMed ID: 33742606
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA GAS5 sensitizes renal cell carcinoma to sorafenib via miR-21/SOX5 pathway.
Liu L; Pang X; Shang W; Xie H; Feng Y; Feng G
Cell Cycle; 2019 Feb; 18(3):257-263. PubMed ID: 29895198
[TBL] [Abstract][Full Text] [Related]
4. miR-28-5p acts as a tumor suppressor in renal cell carcinoma for multiple antitumor effects by targeting RAP1B.
Wang C; Wu C; Yang Q; Ding M; Zhong J; Zhang CY; Ge J; Wang J; Zhang C
Oncotarget; 2016 Nov; 7(45):73888-73902. PubMed ID: 27729617
[TBL] [Abstract][Full Text] [Related]
5. RASSF6-mediated inhibition of Mcl-1 through JNK activation improves the anti-tumor effects of sorafenib in renal cell carcinoma.
Liang YY; Deng XB; Zeng LS; Lin XT; Shao XF; Wang B; Mo ZW; Yuan YW
Cancer Lett; 2018 Sep; 432():75-83. PubMed ID: 29864454
[TBL] [Abstract][Full Text] [Related]
6. MiRNA-30a-mediated autophagy inhibition sensitizes renal cell carcinoma cells to sorafenib.
Zheng B; Zhu H; Gu D; Pan X; Qian L; Xue B; Yang D; Zhou J; Shan Y
Biochem Biophys Res Commun; 2015 Apr; 459(2):234-239. PubMed ID: 25712526
[TBL] [Abstract][Full Text] [Related]
7. Extracellular vesicles derived from M1 macrophages deliver miR-146a-5p and miR-146b-5p to suppress trophoblast migration and invasion by targeting TRAF6 in recurrent spontaneous abortion.
Ding J; Zhang Y; Cai X; Zhang Y; Yan S; Wang J; Zhang S; Yin T; Yang C; Yang J
Theranostics; 2021; 11(12):5813-5830. PubMed ID: 33897883
[No Abstract] [Full Text] [Related]
8. Peglated-H1/pHGFK1 nanoparticles enhance anti-tumor effects of sorafenib by inhibition of drug-induced autophagy and stemness in renal cell carcinoma.
Gao X; Jiang P; Zhang Q; Liu Q; Jiang S; Liu L; Guo M; Cheng Q; Zheng J; Yao H
J Exp Clin Cancer Res; 2019 Aug; 38(1):362. PubMed ID: 31426831
[TBL] [Abstract][Full Text] [Related]
9. miR-224-5p Contained in Urinary Extracellular Vesicles Regulates PD-L1 Expression by Inhibiting Cyclin D1 in Renal Cell Carcinoma Cells.
Qin Z; Hu H; Sun W; Chen L; Jin S; Xu Q; Liu Y; Yu L; Zeng S
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33557163
[TBL] [Abstract][Full Text] [Related]
10. Ubenimex attenuates acquired sorafenib resistance in renal cell carcinoma by inhibiting Akt signaling in a lipophagy associated mechanism.
Liu S; Gao M; Wang X; Ding S; Lv J; Gao D; Wang Z; Niu Z
Oncotarget; 2016 Nov; 7(48):79141-79153. PubMed ID: 27816967
[TBL] [Abstract][Full Text] [Related]
11. Elevated miR-182-5p Associates with Renal Cancer Cell Mitotic Arrest through Diminished
Kulkarni P; Dasgupta P; Bhat NS; Shahryari V; Shiina M; Hashimoto Y; Majid S; Deng G; Saini S; Tabatabai ZL; Yamamura S; Tanaka Y; Dahiya R
Mol Cancer Res; 2018 Nov; 16(11):1750-1760. PubMed ID: 30037856
[TBL] [Abstract][Full Text] [Related]
12. MiR-106a-5p inhibits the cell migration and invasion of renal cell carcinoma through targeting PAK5.
Pan YJ; Wei LL; Wu XJ; Huo FC; Mou J; Pei DS
Cell Death Dis; 2017 Oct; 8(10):e3155. PubMed ID: 29072688
[TBL] [Abstract][Full Text] [Related]
13. Enhanced sensitivity to sorafenib by inhibition of Akt1 expression in human renal cell carcinoma ACHN cells both in vitro and in vivo.
Tei H; Miyake H; Fujisawa M
Hum Cell; 2015 Jul; 28(3):114-21. PubMed ID: 25862630
[TBL] [Abstract][Full Text] [Related]
14. Oncogene miR-154-5p regulates cellular function and acts as a molecular marker with poor prognosis in renal cell carcinoma.
Lin C; Li Z; Chen P; Quan J; Pan X; Zhao L; Zhou L; Lai Y; He T; Xu W; Xu J; Guan X; Li H; Yang S; Hu Y; Lai Y
Life Sci; 2018 Sep; 209():481-489. PubMed ID: 30138594
[TBL] [Abstract][Full Text] [Related]
15. Feedback activation of GATA1/miR-885-5p/PLIN3 pathway decreases sunitinib sensitivity in clear cell renal cell carcinoma.
Yao D; Xia S; Jin C; Zhao W; Lan W; Liu Z; Xiu Y
Cell Cycle; 2020 Sep; 19(17):2195-2206. PubMed ID: 32783497
[TBL] [Abstract][Full Text] [Related]
16. MiR-31-5p acts as a tumor suppressor in renal cell carcinoma by targeting cyclin-dependent kinase 1 (CDK1).
Li Y; Quan J; Chen F; Pan X; Zhuang C; Xiong T; Zhuang C; Li J; Huang X; Ye J; Zhang F; Zhang Z; Gui Y
Biomed Pharmacother; 2019 Mar; 111():517-526. PubMed ID: 30597305
[TBL] [Abstract][Full Text] [Related]
17. Extracellular vesicles derived from paclitaxel-sensitive nasopharyngeal carcinoma cells deliver miR-183-5p and impart paclitaxel sensitivity through a mechanism involving P-gp.
Cui X; Chen Y; Zhao L; Ding X
Cell Biol Toxicol; 2023 Dec; 39(6):2953-2970. PubMed ID: 37296288
[TBL] [Abstract][Full Text] [Related]
18. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of c-FLIPL expression by miRNA-708 increases the sensitivity of renal cancer cells to anti-cancer drugs.
Kim EA; Kim SW; Nam J; Sung EG; Song IH; Kim JY; Kwon TK; Lee TJ
Oncotarget; 2016 May; 7(22):31832-46. PubMed ID: 27092874
[TBL] [Abstract][Full Text] [Related]
20. Extracellular vesicles derived from lung cancer cells promote the progression of lung cancer by delivering miR-151a-5p.
Hu H; Jiang L; Kang X; Zhang L; Zeng S
Exp Cell Res; 2023 Apr; 425(1):113526. PubMed ID: 36828167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
